These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 17241647)
1. Status of forest onchocerciasis in the Lower Cross River Basin, Nigeria: change in clinical and parasitological indices after 6 years of ivermectin intervention. Opara KN; Fagbemi BO; Atting IA; Oyene UE; Okenu DM Public Health; 2007 Mar; 121(3):202-7. PubMed ID: 17241647 [No Abstract] [Full Text] [Related]
2. Status of forest onchocerciasis in the Lower Cross River basin, Nigeria: entomologic profile after five years of ivermectin intervention. Opara KN; Fagbemi OB; Ekwe A; Okenu DM Am J Trop Med Hyg; 2005 Aug; 73(2):371-6. PubMed ID: 16103607 [TBL] [Abstract][Full Text] [Related]
3. Primary motives for demand of ivermectin drug in mass distribution programmes to control onchocerciasis. Abanobi OC; Chukwuocha UM; Onwuiiliri CO; Opara KC East Afr J Public Health; 2011 Mar; 8(1):33-7. PubMed ID: 22066280 [TBL] [Abstract][Full Text] [Related]
4. Seasonal biting pattern of Simulium damnosum s.l and its implications on onchocerciasis treatment with ivermectin. Adewale B; Oyerinde JP; Mafe MA West Afr J Med; 2008 Oct; 27(4):224-9. PubMed ID: 19469400 [TBL] [Abstract][Full Text] [Related]
6. Hanging groin and persistent pruritus in a patient from Burkina Faso. Niamba P; Gaulier A; Taïeb A Int J Dermatol; 2007 May; 46(5):485-6. PubMed ID: 17472676 [TBL] [Abstract][Full Text] [Related]
7. Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries. Brattig NW Acta Trop; 2009 Sep; 111(3):201-2. PubMed ID: 19619685 [No Abstract] [Full Text] [Related]
8. Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment. Mweya CN; Kalinga AK; Kabula B; Malley KD; Ruhiso MH; Maegga BT Tanzan Health Res Bull; 2007 Sep; 9(3):174-9. PubMed ID: 18087895 [TBL] [Abstract][Full Text] [Related]
9. The varied beneficial effects of ivermectin (Mectizan) treatment, as observed within onchocerciasis foci in south-eastern Nigeria. Anosike JC; Dozie IN; Ameh GI; Ukaga CN; Nwoke BE; Nzechukwu CT; Udujih OS; Nwosu DC Ann Trop Med Parasitol; 2007 Oct; 101(7):593-600. PubMed ID: 17877878 [TBL] [Abstract][Full Text] [Related]
10. Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria. Siewe JNF; Ukaga CN; Nwazor EO; Nwoke MO; Nwokeji MC; Onuoha BC; Nwanjor SO; Okeke J; Osahor K; Chimechefulam L; Ogomaka AI; Amaechi AA; Ezenwa CI; Ezike MN; Ikpeama C; Nwachukwu O; Eriama-Joseph AI; Nwoke BEB; Colebunders R Infect Dis Poverty; 2019 Jan; 8(1):8. PubMed ID: 30670093 [TBL] [Abstract][Full Text] [Related]
11. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals. Whitworth JA; Morgan D; Maude GH; Luty AJ; Taylor DW Trans R Soc Trop Med Hyg; 1992; 86(3):277-80. PubMed ID: 1412652 [TBL] [Abstract][Full Text] [Related]
12. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon. Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327 [TBL] [Abstract][Full Text] [Related]
13. Head nodding syndrome and river blindness: a parasitologic perspective. Kaiser C; Pion S; Boussinesq M Epilepsia; 2009 Oct; 50(10):2325-6. PubMed ID: 19785668 [No Abstract] [Full Text] [Related]
14. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786 [TBL] [Abstract][Full Text] [Related]
15. Onchocerciasis: developments in diagnosis, treatment and control. Stingl P Int J Dermatol; 2009 Apr; 48(4):393-6. PubMed ID: 19335425 [No Abstract] [Full Text] [Related]
16. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA. Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245 [TBL] [Abstract][Full Text] [Related]
17. Transmission of Onchocerca volvulus and prospects for the elimination of its vector, the blackfly Simulium neavei in the Mpamba-Nkusi focus in Western Uganda. Lakwo TL; Ndyomugyenyi R; Onapa AW; Twebaze C Med Vet Entomol; 2006 Mar; 20(1):93-101. PubMed ID: 16608493 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms. Bourguinat C; Pion SD; Kamgno J; Gardon J; Gardon-Wendel N; Duke BO; Prichard RK; Boussinesq M Parasitology; 2006 Feb; 132(Pt 2):255-62. PubMed ID: 16197589 [TBL] [Abstract][Full Text] [Related]
19. Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control. Haddad D; Cross C; Thylefors B; Richards FO; Bush S; Hopkins AD; Baker SK Glob Public Health; 2008; 3(2):187-96. PubMed ID: 19288370 [TBL] [Abstract][Full Text] [Related]
20. Limb swelling with hypereosinophilia. Chakvetadze C; Bani-Sadr F; Develoux M; Le Breton C; Pialoux G Lancet; 2006 Sep; 368(9541):1126. PubMed ID: 16997667 [No Abstract] [Full Text] [Related] [Next] [New Search]